# Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO)

> **NCT01205282** · PHASE2 · COMPLETED · sponsor: **Evdokia Anagnostou** · enrollment: 28 (actual)

## Conditions studied

- Autism Spectrum Disorders

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01205282
- **Lead sponsor:** Evdokia Anagnostou
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01205282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01205282, "Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01205282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*